EBA
HARP

Eagle Bay Advisors’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Eagle Bay Advisors’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-140
Closed -$13K – 1037
2021
Q4 		$13K Buy
+140
New +$9.55K 0.01% 661

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Eagle Bay Advisors's HARP Position: Q1 2022 in Review

Eagle Bay Advisors sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2022, closing a stake of 140 shares — an estimated $13K sold.

Eagle Bay Advisors first reported a position in HARP in Q4 2021 and held it in 1 quarter. The position peaked at $13K in Q4 2021. 79 funds tracked by Wall St. Rank hold HARP as of Q1 2022.

  • Eagle Bay Advisors reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Eagle Bay Advisors sold 140 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $13K.
  • Eagle Bay Advisors first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Eagle Bay Advisors's Harpoon Therapeutics, Inc. Common Stock position peaked at $13K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Eagle Bay Advisors's 13F filing for Q1 2022, filed 11 May 2022.